The body uses a signaling network called PGE2 to manage inflammation and cell growth. This system involves four different receptors, known as EP1 through EP4. Depending on which receptor is active, the effects on the body can be very different.
In brain diseases like Alzheimer's and Parkinson's, these receptors act in complex ways. While some parts of the pathway cause harmful inflammation and nerve damage, others may actually help protect brain cells. This means that targeting specific receptors could lead to better treatments for memory loss and movement disorders.
In cancer research, the study found that certain pathways help tumors grow and hide from the immune system. Specifically, the EP2 and EP4 receptors were linked to faster tumor growth in lung and skin cancers. By blocking these specific paths, doctors may be able to slow down cancer progression.
For heart and metabolic health, the results were mixed. Some parts of the pathway helped protect the body, while others caused harm. These findings suggest that instead of using general drugs, future medicines could target only the specific receptors that cause problems in certain diseases.
